Cargando…

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients

BACKGROUND: We investigated the effect of cholinesterase inhibitors on all-cause discontinuation, efficacy and safety, and the effects of study design-, intervention-, and patient-related covariates on the risk-benefit of cholinesterase inhibitors for Alzheimer’s disease. METHODS: A systematic revie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco-Silvente, Lídia, Castells, Xavier, Saez, Marc, Barceló, Maria Antònia, Garre-Olmo, Josep, Vilalta-Franch, Joan, Capellà, Dolors
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Regular Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492783/ https://www.ncbi.nlm.nih.gov/pubmed/28201726 http://dx.doi.org/10.1093/ijnp/pyx012

Ejemplares similares

Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients
por: Blanco-Silvente, Lídia, et al.
Publicado: (2018)

Drug-induced Sudden Death: A Scoping Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2023)

Association of depression phenotypes and antidepressant treatment with mortality due to cancer and other causes: a community-based cohort study
por: Vilalta-Lacarra, Anna, et al.
Publicado: (2023)

What seems to matter in public policy and the health of informal caregivers? A cross-sectional study in 12 European countries
por: Calvó-Perxas, Laia, et al.
Publicado: (2018)

Dopaminergic Dysregulation, Artistic Expressiveness, and Parkinson's Disease
por: López-Pousa, S., et al.
Publicado: (2012)

OUTCOMES OF DISCONTINUING CHOLINESTERASE INHIBITORS IN NURSING HOME RESIDENTS WITH SEVERE DEMENTIA
por: Niznik, Joshua D, et al.
Publicado: (2019)

Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study
por: Garre-Olmo, Josep, et al.
Publicado: (2021)

Reassessment of the dementia diagnosis of Alzheimer's disease in patients enrolled on the cholinesterase inhibitors dispensation program
por: Piovesana, Magda Cristina Flaitt Sanches, et al.
Publicado: (2012)

Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study
por: Garre-Olmo, Josep, et al.
Publicado: (2019)

Placebo Response and Its Predictors in Attention Deficit Hyperactivity Disorder: A Meta-Analysis and Comparison of Meta-Regression and MetaForest
por: Castells, Xavier, et al.
Publicado: (2021)

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis
por: Matsunaga, Shinji, et al.
Publicado: (2015)

Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression
por: Kishi, Taro, et al.
Publicado: (2022)

Influence of Social Determinants of Health on the Quality of Life of Older Adults in Europe: A Sex Analysis
por: Llorens-Ortega, Rafael, et al.
Publicado: (2023)

Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
por: Hyman, David M., et al.
Publicado: (2015)

Cholinesterase inhibitors for gait, balance, and fall in Parkinson disease: a meta-analysis
por: Chen, Jia-Hung, et al.
Publicado: (2021)

Association of Reduced Maternal Plasma Cholinesterase Activity With Preeclampsia: A Meta-Analysis
por: Mohammad, Fouad K, et al.
Publicado: (2023)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Campbell, Noll, et al.
Publicado: (2008)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Matsunaga, Shinji, et al.
Publicado: (2015)

Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
por: Meng, Yan-Hong, et al.
Publicado: (2019)

A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study)
por: Inoriza, José M., et al.
Publicado: (2023)

MiR-106a facilitates the sensorineural hearing loss induced by oxidative stress by targeting connexin-43
por: Ding, Lei, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer's Disease and Other Dementias
por: Muayqil, Taim, et al.
Publicado: (2012)

A meta-analysis of normal human blood cholinesterase activities determined by a modified electrometric method
por: Garmavy, Hishyar Mohammed Salih, et al.
Publicado: (2023)

Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
por: Rodriguez-Poncelas, Antonio, et al.
Publicado: (2013)

Regression discontinuity threshold optimization
por: Marinescu, Ioana, et al.
Publicado: (2022)

Editorial: “We Know What We Are, but Know Not What We May Be”: Metacognition and Self-Awareness in the Aging Brain
por: Orfei, Maria Donata, et al.
Publicado: (2021)

PS106. Nicotinic acetylcholine receptor antagonists for treatment-resistant depression: A meta-analysis.
por: Wang, Hee Ryung, et al.
Publicado: (2016)

Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis
por: Karimi, Saeed, et al.
Publicado: (2021)

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis
por: Kennedy, Richard E., et al.
Publicado: (2018)

First meta-analysis study of cholinesterase inhibition in experimental animals by organophosphate or carbamate insecticides under the influence of diphenhydramine
por: Mohammad, Fouad K., et al.
Publicado: (2023)

Methylmercury-cholinesterase interactions in rats.
por: Hastings, F L, et al.
Publicado: (1975)

Cholinesterase inhibitors from botanicals
por: Ahmed, Faiyaz, et al.
Publicado: (2013)

Cholinesterase inhibitors as Alzheimer's therapeutics
por: Sharma, Kamlesh
Publicado: (2019)

Cholinesterases in Tripartite Neuromuscular Synapse
por: Petrov, Konstantin A., et al.
Publicado: (2021)

Prevalence and related factors of Active and Healthy Ageing in Europe according to two models: Results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
por: Bosch-Farré, Cristina, et al.
Publicado: (2018)

Cholinesterase Research Outreach Project (CROP): measuring cholinesterase activity and pesticide use in an agricultural community
por: Cotton, Jacqueline, et al.
Publicado: (2015)

Cholinesterase research outreach project (CROP): point of care cholinesterase measurement in an Australian agricultural community
por: Cotton, Jacqueline, et al.
Publicado: (2018)

Spatiotemporal path discontinuities of wavepackets propagating across a meta-atom
por: Yoo, Insang, et al.
Publicado: (2014)

Addendum to proposal P 106: consideration on the time scale for P106
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_lvct3m1tpce2l2vi1u87vbtaj7